Novocure names Frank Leonard as CEO [Seeking Alpha]
NovoCure Limited - Ordinary Shares (NVCR)
Last novocure limited - ordinary shares earnings: 4/30 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
novocure.com/investor-relations
Company Research
Source: Seeking Alpha
Leonard previously served as president of Novocure and succeeds Ashley Cordova who has resigned from the company. NVCR premarket. More on NovoCure NovoCure Limited 2025 Q3 - Results - Earnings Call Presentation NovoCure Limited (NVCR) Q3 2025 Earnings Call Transcript NovoCure: Buy Rating As Pipeline Gains Drive Renewed Momentum Novocure outlines four-indication expansion and profitability target for 2027 as GBM growth continues NovoCure Q3 2025 Earnings Preview Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
NVCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVCR alerts
High impacting NovoCure Limited - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
NVCR
News
- NovoCure (NASDAQ:NVCR) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.MarketBeat
- Why NovoCure Is Failing To Disrupt NSCLC [Seeking Alpha]Seeking Alpha
- NovoCure (NASDAQ:NVCR) had its price target lowered by analysts at HC Wainwright from $42.00 to $39.00. They now have a "buy" rating on the stock.MarketBeat
- Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company UpdateBusiness Wire
- NovoCure (NASDAQ:NVCR) was given a new $20.00 price target on by analysts at Evercore ISI.MarketBeat
NVCR
Earnings
- 10/30/25 - Beat
NVCR
Sec Filings
- 1/12/26 - Form 4
- 1/12/26 - Form 8-K
- 1/8/26 - Form 5
- NVCR's page on the SEC website